Safety of carotid artery stenting for elderly patients with cervical carotid artery stenosis.
Carotid artery
elderly
stenosis
stent
Journal
Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences
ISSN: 2385-2011
Titre abrégé: Interv Neuroradiol
Pays: United States
ID NLM: 9602695
Informations de publication
Date de publication:
Aug 2020
Aug 2020
Historique:
pubmed:
24
1
2020
medline:
4
5
2021
entrez:
24
1
2020
Statut:
ppublish
Résumé
Several recent randomized controlled trials have reported that perioperative complications of carotid artery stenting increase with age, and Japan has the highest proportion of elderly in the world. We retrospectively compared clinical factors, treatment outcomes, and adverse events between younger and elderly carotid artery stenting patients at a single institution in Japan to assess carotid artery stenting safety for the aged population. A total of 150 consecutive patients treated with carotid artery stenting using the dual protection (simultaneous flow reversal and distal filter) and blood aspiration method were enrolled. Patients were classified into an elderly (O) group ≥75 years (54/150, 36.0%) and a younger (Y) group <75 years (96/150, 64%) for comparison of demographics, clinical background, incidence of captured debris during the procedure, outcome, minor stroke, major adverse events (major stroke, myocardial infarction, or death) within 30 days, hyperintense spots on diffusion-weighted images after carotid artery stenting, and postoperative hospitalization days. The carotid artery stenting procedure was successful in all cases. No major adverse events occurred within 30 days in the Y group, and only one occurred in the O group ( Carotid artery stenting using dual protection and blood aspiration is equally safe for younger and elderly patients.
Sections du résumé
BACKGROUND
BACKGROUND
Several recent randomized controlled trials have reported that perioperative complications of carotid artery stenting increase with age, and Japan has the highest proportion of elderly in the world. We retrospectively compared clinical factors, treatment outcomes, and adverse events between younger and elderly carotid artery stenting patients at a single institution in Japan to assess carotid artery stenting safety for the aged population.
METHODS
METHODS
A total of 150 consecutive patients treated with carotid artery stenting using the dual protection (simultaneous flow reversal and distal filter) and blood aspiration method were enrolled. Patients were classified into an elderly (O) group ≥75 years (54/150, 36.0%) and a younger (Y) group <75 years (96/150, 64%) for comparison of demographics, clinical background, incidence of captured debris during the procedure, outcome, minor stroke, major adverse events (major stroke, myocardial infarction, or death) within 30 days, hyperintense spots on diffusion-weighted images after carotid artery stenting, and postoperative hospitalization days.
RESULTS
RESULTS
The carotid artery stenting procedure was successful in all cases. No major adverse events occurred within 30 days in the Y group, and only one occurred in the O group (
CONCLUSIONS
CONCLUSIONS
Carotid artery stenting using dual protection and blood aspiration is equally safe for younger and elderly patients.
Identifiants
pubmed: 31969075
doi: 10.1177/1591019919900831
pmc: PMC7446589
doi:
Substances chimiques
Platelet Aggregation Inhibitors
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
439-445Références
N Engl J Med. 2016 Mar 17;374(11):1011-20
pubmed: 26886419
Ann Vasc Surg. 2014 Apr;28(3):651-8
pubmed: 24378246
Neurosurg Rev. 2015 Oct;38(4):671-6
pubmed: 25953614
Stroke. 2014 Jul;45(7):2160-236
pubmed: 24788967
J Neurointerv Surg. 2016 Oct;8(10):1011-5
pubmed: 26453607
Ann Med. 2016 Nov;48(7):541-551
pubmed: 27595161
Neurol Med Chir (Tokyo). 2009 Sep;49(9):386-93
pubmed: 19779282
World Neurosurg. 2018 Nov;119:e323-e327
pubmed: 30055369
J Vasc Surg. 2007 Nov;46(5):841-5
pubmed: 17980267
J Vasc Surg. 2004 Dec;40(6):1106-11
pubmed: 15622363
Lancet. 1998 May 9;351(9113):1379-87
pubmed: 9593407
JAMA. 1995 May 10;273(18):1421-8
pubmed: 7723155
Lancet. 2016 Mar 26;387(10025):1305-11
pubmed: 26880122
Stroke. 2011 Sep;42(9):2550-5
pubmed: 21737811
J Am Coll Cardiol. 2012 Apr 10;59(15):1383-9
pubmed: 22284330
Acta Neurochir (Wien). 2015 Mar;157(3):371-7
pubmed: 25547718
N Engl J Med. 1991 Aug 15;325(7):445-53
pubmed: 1852179
Int J Cardiol. 2014 Sep 20;176(2):478-83
pubmed: 25125014
N Engl J Med. 1998 Nov 12;339(20):1415-25
pubmed: 9811916
N Engl J Med. 2006 Oct 19;355(16):1660-71
pubmed: 17050890
Lancet. 1991 May 25;337(8752):1235-43
pubmed: 1674060
Lancet. 2010 Mar 20;375(9719):985-97
pubmed: 20189239
N Engl J Med. 2004 Oct 7;351(15):1493-501
pubmed: 15470212
Lancet. 2006 Oct 7;368(9543):1239-47
pubmed: 17027729
N Engl J Med. 2010 Jul 1;363(1):11-23
pubmed: 20505173
J Endovasc Ther. 2007 Jun;14(3):293-303
pubmed: 17723007
J Am Coll Cardiol. 2011 Oct 11;58(16):1656-63
pubmed: 21982309
J Vasc Surg. 2012 Dec;56(6):1585-90
pubmed: 22960021
Acta Neurochir (Wien). 2012 Dec;154(12):2127-37
pubmed: 23053283
JACC Cardiovasc Interv. 2013 Nov;6(11):1203-9
pubmed: 24262620
Lancet. 2004 May 8;363(9420):1491-502
pubmed: 15135594
Neurosurg Rev. 2010 Oct;33(4):419-30
pubmed: 20563621
Catheter Cardiovasc Interv. 2017 Apr;89(5):923-931
pubmed: 27862881